Plasmodium vivax infection in Anajas, State of Para: no differential resistance profile among Duffy-negative and Duffy-positive individuals

  • Carvalho T
  • Queiroz M
  • Cardoso G
 et al. 
  • 30


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


BACKGROUND: There is large body of evidence that states that invasion of Plasmodium vivax requires the Duffy antigen, but the universality of this specificity is certainly now under question with recent reports showing that in some parts of the world P. vivax infects and causes disease in Duffy-negative people. These findings reinforce the idea that this parasite is rapidly evolving, being able to use other receptors than Duffy to invade the erythrocytes, which may have an enormous impact in P. vivax current distribution. The presence of P. vivax infection in Duffy-negative individuals was investigated in a cross-sectional study conducted in Anajas, Archipelago of Marajo, State of Para, which is an area of malaria transmission in the Brazilian Amazonia. METHODS: Duffy genotyping and Plasmodium species diagnostic assays were performed successfully in 678 individuals. An allele-specific primer polymerase chain reaction (PCR) technique was used for Duffy blood group genotyping. Identification of Plasmodium species was achieved by conventional blood smear light microscopy and a TaqMan-based real-time PCR method to detect mitochondrial genome of Plasmodium falciparum and P. vivax. RESULTS: Plasmodium spp. infection was detected in 137 samples (20.2%). Prevalence of each Plasmodium species was 13.9% P. vivax, 5.8% P. falciparum, and 0.6% P. vivax plus P. falciparum. Overall, 4.3% (29/678) were genotyped as Duffy-negative (FY*BES/*BES). Among Duffy-negative individuals 6.9% were P. vivax PCR positive and among Duffy-positive 14.2% were P. vivax PCR positive. Although lower, the risk of Duffy-negatives to experience a P. vivax blood stage infection was not significantly different to that of Duffy-positives. Furthermore, the genotypic and allelic frequencies of the Duffy blood group among P. vivax-infected patients and in the control group did not differ significantly, also suggesting no reduction in infection rates among the carriers of FY*BES allele. CONCLUSIONS: The data obtained in Anajas showed no differential resistance vivax malaria among Duffy-negative and Duffy-positive individuals. This result needs additional confirmation through a deeper evaluation in a larger sample of patients with P. vivax malaria and molecular parasite characterization. Nonetheless, this genetic profile of the parasite may be contributing to the high incidence of malaria in the municipality.

Author-supplied keywords

  • *Duffy Blood-Group System/genetics
  • Base Sequence
  • Brazil/epidemiology
  • Cross-Sectional Studies
  • DNA/genetics
  • Falciparum/blood/epidemiology/genetics/pa
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Host-Parasite Interactions/genetics
  • Humans
  • Malaria
  • Plasmodium vivax/genetics/pathogenicity
  • Vivax/*blood/epidemiology/genetics/parasi

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in


  • T A Carvalho

  • M G Queiroz

  • G L Cardoso

  • I G Diniz

  • A N Silva

  • A Y Pinto

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free